Search research articles
Contact Us
Filters
Showing results (11-20 of 30) with videos related to
Page
of 3
Sort By:
Scientific Reports
|
December 17, 2016
Harnessing the natural inhibitory domain to control TNFα Converting Enzyme (TACE) activity in vivo
Eitan Wong, Tal Cohen, Erez Romi, et al.
The Journal of Rheumatology
|
January 17, 2016
Longterm Efficacy of an Antipneumococcal Polysaccharide Vaccine among Patients with Autoimmune Inflammatory Rheumatic Diseases
Adi Broyde, Uri Arad, Noa Madar-Balakirski, et al.
European Journal of Medicinal Chemistry
|
October 15, 2019
Structure-activity relationship study of NPP1 inhibitors based on uracil-N1-(methoxy)ethyl-β-phosphate scaffold
Molhm Nassir, Julie Pelletier, Uri Arad, et al.
Rheumatology (Oxford, England)
|
April 25, 2018
Inhibition of nucleotide pyrophosphatase/phosphodiesterase 1: implications for developing a calcium pyrophosphate deposition disease modifying drug
Ortal Danino, Shuli Svetitsky, Sarah Kenigsberg, et al.
Cytokine
|
February 18, 2015
Galectin-3 is a sensor-regulator of toll-like receptor pathways in synovial fibroblasts
Uri Arad, Noa Madar-Balakirski, Avital Angel-Korman, et al.
Rheumatology International
|
October 25, 2019
Prevalence of high-sensitivity cardiac troponin T in real-life cohorts of psoriatic arthritis and general population: a cross-sectional study
Victoria Furer, Shani Shenhar-Tsarfaty, Shlomo Berliner, et al.
Purinergic Signalling
|
April 27, 2019
Identification of adenine-N9-(methoxy)ethyl-β-bisphosphonate as NPP1 inhibitor attenuates NPPase activity in human osteoarthritic chondrocytes
Molhm Nassir, Uri Arad, Sang-Yong Lee, et al.
Purinergic Signalling
|
July 22, 2019
Correction to: Identification of adenine-N9-(methoxy)ethyl-β-bisphosphonate as NPP1 inhibitor attenuates NPPase activity in human osteoarthritic chondrocytes
Molhm Nassir, Uri Arad, Sang-Yong Lee, et al.
Clinical Rheumatology
|
November 23, 2014
The fine line between Takayasu arteritis and giant cell arteritis
Ari Polachek, Rachel Pauzner, David Levartovsky, et al.
Current Medical Research and Opinion
|
March 24, 2018
Expression levels of selected genes can predict individual rheumatoid arthritis patient response to tumor necrosis factor alpha blocker treatment
Daphna Paran, Yoav Smith, Shlomo Pundak, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 30) with videos related to
Sort By:
Page
of 3
Scientific Reports
|
December 17, 2016
Harnessing the natural inhibitory domain to control TNFα Converting Enzyme (TACE) activity in vivo
Eitan Wong, Tal Cohen, Erez Romi, et al.
The Journal of Rheumatology
|
January 17, 2016
Longterm Efficacy of an Antipneumococcal Polysaccharide Vaccine among Patients with Autoimmune Inflammatory Rheumatic Diseases
Adi Broyde, Uri Arad, Noa Madar-Balakirski, et al.
European Journal of Medicinal Chemistry
|
October 15, 2019
Structure-activity relationship study of NPP1 inhibitors based on uracil-N1-(methoxy)ethyl-β-phosphate scaffold
Molhm Nassir, Julie Pelletier, Uri Arad, et al.
Rheumatology (Oxford, England)
|
April 25, 2018
Inhibition of nucleotide pyrophosphatase/phosphodiesterase 1: implications for developing a calcium pyrophosphate deposition disease modifying drug
Ortal Danino, Shuli Svetitsky, Sarah Kenigsberg, et al.
Cytokine
|
February 18, 2015
Galectin-3 is a sensor-regulator of toll-like receptor pathways in synovial fibroblasts
Uri Arad, Noa Madar-Balakirski, Avital Angel-Korman, et al.
Rheumatology International
|
October 25, 2019
Prevalence of high-sensitivity cardiac troponin T in real-life cohorts of psoriatic arthritis and general population: a cross-sectional study
Victoria Furer, Shani Shenhar-Tsarfaty, Shlomo Berliner, et al.
Purinergic Signalling
|
April 27, 2019
Identification of adenine-N9-(methoxy)ethyl-β-bisphosphonate as NPP1 inhibitor attenuates NPPase activity in human osteoarthritic chondrocytes
Molhm Nassir, Uri Arad, Sang-Yong Lee, et al.
Purinergic Signalling
|
July 22, 2019
Correction to: Identification of adenine-N9-(methoxy)ethyl-β-bisphosphonate as NPP1 inhibitor attenuates NPPase activity in human osteoarthritic chondrocytes
Molhm Nassir, Uri Arad, Sang-Yong Lee, et al.
Clinical Rheumatology
|
November 23, 2014
The fine line between Takayasu arteritis and giant cell arteritis
Ari Polachek, Rachel Pauzner, David Levartovsky, et al.
Current Medical Research and Opinion
|
March 24, 2018
Expression levels of selected genes can predict individual rheumatoid arthritis patient response to tumor necrosis factor alpha blocker treatment
Daphna Paran, Yoav Smith, Shlomo Pundak, et al.
Page
of 3